I think this information is very important, but again, just to start a process of formal, well-designed evaluation and studies. I think there are no shortcuts, and shortcuts may be dangerous.
When you want to treat, and when you want to evaluate a new treatment, there are different steps for that, which include a randomized trial where you have well-designed studies according to international standards where you will compare a new treatment to another condition. This has to be very specifically designed, of course, which allows us to get the results we need to see if we use that intervention or not.